Introduction Cancer associated venous thromboembolism (CAT) is one of the leading cause
of morbidity and mortality in the cancer population. Multiple scoring systems have been …

We aimed to evaluate the performance of the Khorana score in predicting venous
thromboembolic events in ambulatory cancer patients. Embase and MEDLINE were …

Aim: We performed a systematic review and meta-analysis to provide high-level evidence on
the performance of the Khorana score in predicting VTE in patients with different types of …

Abstract Background Risk assessment models (RAMs) are relevant approaches to identify
cancer outpatients at high risk of venous thromboembolism (VTE). Among the proposed …

Background Oncology guidelines suggest using the Khorana score to select ambulatory
cancer patients receiving chemotherapy for primary venous thromboembolism (VTE) …

Cancer-associated venous thromboembolism (VTE) is one of the leading causes of mortality
and morbidity among patients with malignancy. The Khorana risk score (KRS) is currently …

Introduction: Venous thromboembolism (VTE) is common in cancer patients and associated
with adverse consequences. Risk factors for cancer-associated VTE are multifactorial and a …

Background The Khorana risk score (KRS) for prognosis of venous thromboembolism (VTE)
has been rarely explored in Hispanic populations. Objective To determine the value of the …

Introduction: Khorana score (KS) stratifies patients into low, intermediate, and high risk
groups for venous thromboembolism (VTE). We examined the generalizability of the KS to …

Since the development of the Khorana score to predict risk of cancer‐associated venous
thromboembolism (VTE), many modified and de novo risk prediction models (RPMs) have …